www.dailypolitical.com ·
needham company llc has lowered expectations for doximity nysedocs stock price
Topic context
This topic has been covered 339649 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe news is a single-stock analyst downgrade for Doximity (NYSE:DOCS), a healthcare technology platform. No commodity, supply chain, or broad sector mechanism is triggered. The commercial impact is limited to the company's valuation and investor sentiment. No concrete commercial mechanism affecting products, supply chains, or scarcity.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Needham & Company reduced Doximity price target from $55 to $27, maintaining 'buy' rating.
- Doximity shares opened at $18.93, market cap $3.50B, 52-week range $17.15-$76.51.
- Insiders own 31.30% of the company; recent insider sales by Siddharth Sitaram and Kira Scherer Wampler.
Doximity shares down 1-5% in response to analyst downgrade within 48h.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- GLOBAL_TECHshort
Related stories
finance.yahoo.com
health tech q1 2026 earnings 215402558
finance.yahoo.com
ncmi q1 2026 earnings transcript 154748256
foreignpolicy.com
eu sanctions russia abductions ukraine children
indianexpress.com
anupreet randhawa arrest land acquisition embezzlement case 10692579
finance.yahoo.com